期刊文献+

非黏附性液体栓塞剂治疗脑动静脉畸形 被引量:4

Treatment of cerebral arteriovenous malformations with Onyx
下载PDF
导出
摘要 目的 探讨新型液态栓塞剂Onyx栓塞脑动静脉畸形的技术要点和临床效果。 方法 对21例脑动静脉畸形患者采用Seldinger技术在股动脉内置入6 F鞘,6 F导引导管进入颈内动脉或椎动脉,以Ultraflow微导管超选择进入畸形团内,采用"阻断和前推技术"长时间缓慢注射Onyx栓塞脑动静脉畸形。本组患者中有13例动静脉畸形位于功能区(运动区、语言区、视觉中枢),6例位于大脑半球深部,2例位于小脑半球。畸形团大小为3 cm的9例,3-6 em的8例,6 cm以上的4例。 结果 治疗后脑动静脉畸形的体积缩小程度为20%-100%。初期因使用Onyx经验不足,在拔出微导管时有2例患者发生严重脑出血,行外科手术救治,其余19例患者无严重并发症。 结论 Onyx栓塞技术可作为治疗体积较大、位于大脑深部及功能区脑动静脉畸形的重要方法之一,长期疗效有待随访结果的验证。 Objective To discuss the techniques and efficacy of embolization in treating cerebral arteriovenous malformations (AVMs) using a new liquid embolic agent (Onyx) . Methods 6 F sheath was inserted into femoral artery, then 6 F guiding catheter was introduced into the internal carotid artery or vertebral artery, Ultraflow microcatheter was navigated into the nidus of AVMs, Onyx-18 was injected into the nidus of cerebral AVM slowly using the 'plug and push technique' . 13 cases of cerebral AVMs were located in functional area, 6 cases in deep cerebral area, and 2 cases in cerebellar hemisphere. The diameter of AVMs was about 3cm in 9 cases, 3 - 6cm in 8 cases, and larger than 6cm in 4 cases. Results 20% -100% embolization was achieved in all cases, 40% in early stage of treatment, and nearly 80% at present. In the initial stage, there was severe cerebral bleeding induced by microcatheter withdrew in 2 cases because of the lack of enough experience. and underwent surgical treatment. However, the other 19 AVM cases with Onyx embolization were treated successfully without severe complications. Conclusion Onyx has unique and distinctive superiority in treating cerebral AVMs with large size and located in deep or functional areas. However, the long-term efficacy of Onyx embolization needs to be followed up.
出处 《中国脑血管病杂志》 CAS 2004年第10期438-441,共4页 Chinese Journal of Cerebrovascular Diseases
关键词 脑动静脉畸形 治疗 患者 液体栓塞剂 微导管 黏附性 SELDINGER技术 Intracranial arteriovenous malformations Blood vessel Chemoembolization, therapeutic Onyx
  • 相关文献

参考文献9

  • 1[1]Fournier D, TerBrugge KG, Willinsky R, et al. Endovascular treatment of intracerebral arteriovenous malformation: experience in 49 cases. J Neurosurg, 1991, 75: 228-233.
  • 2[2]Debrun GM, Aletich V, Ausman JI, et al. Embolization of nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery, 1997, 40: 112-121.
  • 3[3]Duffner F, Ritz R, Bornemann A, et al. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol, 2002,21: 13-17.
  • 4[4]Akin ED, Perkins E, Ross IB. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine. J Neurosurg, 2003, 98: 366-370.
  • 5[5]Fournier D, Terbrugge KG, Rodesch G, et al. Revascularization of brain arteriovenous malformations after embolization with bucrylate. Neuroradiology, 1990, 32: 497-501.
  • 6[6]Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg, 1996, 85: 19-28.
  • 7宋冬雷.ONYX在脑血管病介入治疗中的应用[J].中国现代神经疾病杂志,2004,4(1):15-18. 被引量:20
  • 8宋冬雷,冷冰,徐荣,顾宇翔,周良辅,陈衔城.Onyx治疗中~大型与巨大型脑动脉瘤和动静脉畸形[J].中国临床神经科学,2003,11(4):383-386. 被引量:13
  • 9[9]Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery, 2001, 48: 984-995.

二级参考文献19

  • 1[1]Peerless S J, Wallace MC, Drake CG. Giant intracranial aneurysms.In: Youmans JR, ed. Neurological surgery: a comprehensive reference guide to the diagnosis and management of neurosurgical problems. 3 rd ed. Philadephia: WB Saunders, 1990. 1742-1795.
  • 2[2]Gruber A, Killer M, Bavinzki G, et al. Clinical and angiographic results of endovascular coiling treatment of giant and very large intracranial aneurysms: a 7-year, single-center experience. Neurosurgery, 1999, 45:793-803.
  • 3[3]Mawad ME, Cekirge S, Ciceri E, et al. Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection. J Neurosurg, 2002, 96:474-482.
  • 4[4]Molyneux AJ. ONYX liquid embolic system in the treatment of cerebral aneurysms: where are we now? Neurointerventionist, 2002, 3:92-96.
  • 5[5]Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg, 1996, 85:19-28.
  • 6[6]Duffner F, Ritz R, Bornemann A, et al. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA). Clin Neuropathol, 2002, 21:13-17.
  • 7[7]Akin ED, Perkins E, Ross IB. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine. J Neurosurg, 2003, 98:366-370.
  • 8[8]Jahan R, Murayama Y, Gobin YP, et al. Embolization of arteriovenous malformations with ONYX: clinicopathological experience in 23 patients. Neurosurgery, 2001, 48:984-995.
  • 9[9]Warakaulle DR, Aviv RI, Niemann D, et al. Embolisation of spinal dural arteriovenous fistulae with Onyx. Neuroradiology, 2003, 45:110-112.
  • 10[10]Molyneux A J, Coley SC. Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system): report of two cases.J Neurosurg, 2000, 93 (2 Suppl):304-308.

共引文献26

同被引文献49

  • 1宋冬雷.ONYX在脑血管病介入治疗中的应用[J].中国现代神经疾病杂志,2004,4(1):15-18. 被引量:20
  • 2朱继,唐文渊,孙晓川,张晓东.Onyx胶栓塞治疗脑动静脉畸形应用价值[J].第三军医大学学报,2005,27(23):2373-2375. 被引量:7
  • 3宋冬雷,冷冰,徐斌,王启弘,陈衔城,周良辅.新型液态栓塞剂栓塞脑动静脉畸形70例经验总结[J].中华外科杂志,2007,45(4):223-225. 被引量:16
  • 4方兵,李铁林,段传志,王义荣,汪求精,赵庆平.α-氰基丙烯酸正丁酯栓塞治疗脑动静脉畸形引起的引流静脉损伤和出血并发症的关系[J].中华放射学杂志,2007,41(7):740-742. 被引量:4
  • 5Ledezma CJ, Hoh BL, Carter BS,et al. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery, 2006,58:602-611.
  • 6Hamada JI, Kai Y, Mizuno T, et al. A nonadhesive liquid em- bolie agent of ethylene vinyl alcohol eopolymer and ethanol mixture for cerebral arteriovenous malformations. Clinical experience. Interv Neuroradiol,2004,10 Suppl 1 : 135-142.
  • 7Sasaki T, Kurita H, Saito I,et al. Arteriovenous malformations in the basal ganglia and thalamus: management and results in 101 cases. J Neurosurg, 1998 ,88:285-292.
  • 8Yamamoto M, Jimbo M, Ide M,et al. Gamma knife radiosurgery for cerebral arteriovenous malformations : an autopsy report focusing on irradiation-induced changes observed in nidus- unrelated arteries. Surg Neurol, 1995,44:421-427.
  • 9Guo WY, Wu YT, Wu HM, et al. Toward normal perfusion after radiosurgery: perfusion MR Imaging with independent component analysis of brain arteriovenous malformations. AJNR Am J Neuroradiol, 2004,25 : 1636 - 1644.
  • 10Kihlstrom L, Guo WY, Karlsson B, et al. Magnetic resonance imaming of obliterated arteriovenous malformations up to 23 years after radiosurgery. J Neurosurg,1997 ,86:589-593.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部